Table 2. Fold change ratios in the gene expression of septic patients compared to the healthy volunteers at admission and after seven days of follow-up, according to the outcomes.
D0 | D7 | |||
---|---|---|---|---|
Gene | All (N = 16) | S (N = 8) | NS(N = 8) | All (N = 10) |
TLR4 | 1.08 | -1.06 | 1.25 | 1.05 |
CD14 | 1.17 | 1.05 | 1.34 | -1.11 |
LY96 | 1.1 | 1.02 | 1.24 | -1.12 |
MYD88 | 1.1 | -1.06 | 1.25 | -1.01 |
IRAK3 | 1.41 | 1.21 | 1.64 a | 1.3 |
TRAF6 | -1.81 a | -1.70 a | -2.14 a | -1.47 |
ECSIT | -1.3 | -1.31 | -1.35 | -1.23 |
IRF5 | -1.22 | -1.08 | -1.35 | -1.11 |
CHUK | -1.04 | -1.21 | 1.01 | -1.1 |
IKBKG | -1.12 | -1.09 | -1.14 | 1.09 |
NFKBIA | 1.22 | -1.21 | 1.62 | 1.35 |
NFKB1 | 1.09 | 1.17 | 1.08 | -1.16 |
RELA (p65) | -1.41 | -1.38 | -1.45 | -1.34 |
MAPK7 (ERK) | -1.86 a | -1.69 a | -2.14 a | -1.66 a |
MAP2K3 (MKK3) | 1.29 | 1.2 | 1.52 a | 1.05 |
MAPK14 | 1.24 | 1.21 | 1.32 | 1.25 |
MAP2K7 (MKK7) | -1.49 | -1.39 | -1.66 a | -1.25 |
MAPK8 (JNK1) | -1.74 a | -1.69 a | -1.85 a | -1.41 |
JUN (AP1) | -2.05 a | -1.70 | -2.78 a | -1.43 |
TICAM1 | -1.11 | -1.33 | 1 | -1.17 |
IRF7 | -1.54 a | -1.73 a | -1.50 | -1.35 |
IRF3 | -1.61 a | -1.58 | -1.70 a | -1.37 |
IFNAR1 | -1.23 | -1.08 | -1.51 a | -1.27 |
IFNAR2 | -1.2 | -1.12 | -1.39 | -1.53 |
JAK1 | -1.80 a | -1.68 a | -2.22 a | -1.64 |
TYK2 | -1.37 | -1.31 | -1.47 | -1.29 |
STAT1 | -1.78 a | -2.46 a | -1.80 | -1.13 |
STAT2 | -1.58 a | -1.72 | -1.77 a | -1.36 |
IRF9 | -1.52 a | -1.66 a | -1.61 a | -1.19 |
IFNGR1 (IFNGR) | 1.04 | 1.13 | 1.04 | 1.11 |
IFNGR2 (AF-1) | 1.46 | 1.4 | 1.60 a | 1.23 |
JAK2 | -1.48 | -1.69 | -1.57 | -1.17 |
SOCS3 | -1.07 | -1.02 | -1.22 | -1.23 |
IRF1 | -1.94 a | -2.37 a | -2.17 a | -1.36 |
NOS1 | 1 | -1.35 | 1.46 | -1.4 |
NOS2 | -1.09 | -1.02 | -1.12 | -1.34 |
NOS3 | -2.54 | -1.91 | -3.52 a | -1.85 |
SOD1 | -1.6 | -1.4 | -2.02 a | -1.56 a |
SOD2 | 2.15 a | 1.37 | 3.45 a | 2.12 a |
SOD3 | -1.35 | -1.59 | 1.03 | -1.12 |
CYBB (gp91) | -1.1 | -1.35 | 1.11 | -1.1 |
NCF1 (p47phox) | 1.15 | -1.06 | 1.52 | 1.56 |
RAC1 | -1.03 | -1.05 | -1.12 | -1.04 |
UCP2 | -1.31 | -1.42 | -1.38 | -1.1 |
GPX1 | 1.34 | 1.41 | 1.46 | 1.58 a |
PRDX3 | -1.07 | -1.02 | -1.27 | -1.17 |
PRDX4 | -1.04 | 1.13 | -1.35 | 1 |
CAT | 1 | -1.02 | -1.03 | -1.15 |
TXN | 1.11 | 1.1 | 1.17 | 1.03 |
TXNRD1 | -1.12 | -1.11 | -1.22 | -1.07 |
TXNRD2 | -1.22 | -1.22 | -1.26 | -1.21 |
NDUFA4 | -1.41 | -1.37 | -1.55 a | -1.31 |
NDUFA5 | -1.41 | -1.06 | -1.86 a | -1.22 |
NDUFA7 | -1.35 | -1.34 | -1.54 a | -1.26 |
NDUFA8 | -1.18 | -1.17 | -1.28 | -1.11 |
NDUFA9 | -1.38 | -1.37 | -1.49 | -1.21 |
NDUFA10 | -1.39 | -1.28 | -1.57 a | -1.28 |
NDUFA11 | -1.19 | -1.15 | -1.16 | -1.21 |
NDUFB5 | -1.45 | -1.35 | -1.73 a | -1.33 |
NDUFB6 | -1.37 | -1.31 | -1.58 a | -1.22 |
NDUFC2 | -1.90 a | -1.77 | -2.31 a | -1.58 a |
COX4I2 | -1.83 a | -1.91 | -1.62 | -1.39 |
COX5A | -1.15 | -1.02 | -1.36 | -1.16 |
COX5B | -1.29 | -1.33 | -1.28 | -1.19 |
COX6A2 | 1.18 | -1.01 | 1.31 | -1.26 |
COX7A2 | -1.29 | -1.12 | -1.59 a | -1.36 |
COX7C | -1.49 | -1.4 | -1.67 a | -1.34 |
COX10 | -1.66 a | -1.65 | -1.74 a | -1.30 |
ATP5B | -1.2 | -1.16 | -1.27 | -1.17 |
ATP5C1 | -1.32 | -1.22 | -1.56 a | -1.28 |
ATP5F1 | -1.4 | -1.26 | -1.76 a | -1.34 |
ATP5J | -1.18 | -1.12 | -1.33 | -1.18 |
ATP6V1C1 | 1.22 | 1.24 | 1.12 | 1.04 |
ATP6V1E1 | -1.17 | -1.13 | -1.23 | -1 |
ATP6V1E2 | -1.56 | -1.28 | -1.97 a | -1.51 a |
UQCRC2 | -1.41 | -1.46 | -1.43 | -1.29 |
TNF | 1.04 | -1.99 | 1.54 | 1.3 |
IL1B | 1.38 | -2.24 | 2.9 | 1.56 |
IFNA1 | -1.04 | -1.05 | 1.18 | -1.16 |
IFNB1 | 1.12 | -1.49 | 1.67 | 1.58 |
IL10 | 1.96 | 2.87 a | 1.73 | 1.22 |
IL6 | 3.6 | 1.08 | 7.42 | 2.23 |
CXCL10 | -2.49 | -5.16 | -2.02 | -1.49 |
IL12A | -1.5 | -1.28 | -2.29 a | -1.22 |
Footnote: D0 represents total septic patients after admission and D7 represents samples obtained after 7 days. S: survivors and NS: non-survivors. The bold letters show fold change ≥1.5 and the letter “a” indicates P value ≤0.05.